These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 15528307

  • 1. The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells.
    Bryant W, Snowhite AE, Rice LW, Shupnik MA.
    Endocrinology; 2005 Feb; 146(2):751-9. PubMed ID: 15528307
    [Abstract] [Full Text] [Related]

  • 2. A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression.
    Chaidarun SS, Alexander JM.
    Mol Endocrinol; 1998 Sep; 12(9):1355-66. PubMed ID: 9731704
    [Abstract] [Full Text] [Related]

  • 3. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
    Sirianni R, Zolea F, Chimento A, Ruggiero C, Cerquetti L, Fallo F, Pilon C, Arnaldi G, Carpinelli G, Stigliano A, Pezzi V.
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
    [Abstract] [Full Text] [Related]

  • 4. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH, Rowan BG.
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [Abstract] [Full Text] [Related]

  • 6. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
    Monroe DG, Secreto FJ, Subramaniam M, Getz BJ, Khosla S, Spelsberg TC.
    Mol Endocrinol; 2005 Jun 17; 19(6):1555-68. PubMed ID: 15802376
    [Abstract] [Full Text] [Related]

  • 9. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
    Levy N, Zhao X, Tang H, Jaffe RB, Speed TP, Leitman DC.
    Endocrinology; 2007 Jul 17; 148(7):3449-58. PubMed ID: 17395694
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of the novel estrogen receptor-alpha intronic TERP-1 promoter by estrogens, androgen, pituitary adenylate cyclase-activating peptide, and forskolin, and autoregulation by TERP-1 protein.
    Bryant WM, Gibson MA, Shupnik MA.
    Endocrinology; 2006 Jan 17; 147(1):543-51. PubMed ID: 16210360
    [Abstract] [Full Text] [Related]

  • 11. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC, Zeng Z, McQuown JR, Simmen FA, Simmen RC.
    Mol Endocrinol; 2007 Dec 17; 21(12):2988-3001. PubMed ID: 17717078
    [Abstract] [Full Text] [Related]

  • 12. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM, Shupnik MA.
    Mol Endocrinol; 2005 Nov 17; 19(11):2660-70. PubMed ID: 15976008
    [Abstract] [Full Text] [Related]

  • 13. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
    Shipley JM, Waxman DJ.
    Toxicol Appl Pharmacol; 2006 Jun 01; 213(2):87-97. PubMed ID: 16257430
    [Abstract] [Full Text] [Related]

  • 14. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S, Turgeman G, Harris SE, Leitman DC, Komm BS, Bodine PV, Gazit D.
    Mol Endocrinol; 2003 Jan 01; 17(1):56-66. PubMed ID: 12511606
    [Abstract] [Full Text] [Related]

  • 15. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB, Deighton-Collins S, Martinez A, Kleerekoper M, Zhao C, Benjamins JA, Skafar DF.
    Neuro Endocrinol Lett; 2005 Oct 01; 26(5):526-32. PubMed ID: 16264406
    [Abstract] [Full Text] [Related]

  • 16. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ, Karmakar S, Pace MC, Gao T, Smith CL.
    Mol Cell Biol; 2007 Sep 01; 27(17):5933-48. PubMed ID: 17591692
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 18. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A, Miksicek RJ.
    Mol Endocrinol; 2000 May 01; 14(5):634-49. PubMed ID: 10809228
    [Abstract] [Full Text] [Related]

  • 19. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A, Song J, Tivon D, Hamza A, Cardozo T, Naftolin F.
    Reprod Sci; 2015 Feb 01; 22(2):146-55. PubMed ID: 25258361
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.
    Duplessis TT, Williams CC, Hill SM, Rowan BG.
    Endocrinology; 2011 Jun 01; 152(6):2517-26. PubMed ID: 21505052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.